Skip to content
Genpharmasec logo

Genpharmasec

531592 BSE
Price unavailable

Genpharmasec (GENPHARMA) share price was ₹0.97 at the 28 Oct 2026 close; market capitalisation ₹53.69 Cr; sector Commercial Services. The share price fell 45.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 312.9% year on year to ₹49.71 Cr and net profit was −₹0.17 Cr, against ₹1.22 Cr a year earlier (compared with Jun 2025). Promoters held 32.06% of Genpharmasec in Sep 2026, up 2.08 percentage points from Jun 2026. Its Tapetide Score is 45/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.97 −0.81 −45.51% 1Y

Key Fundamentals

MicrocapCommercial ServicesServices
Market Cap
₹53.69 Cr
EBITDA
₹4.40 Cr
Return on Equity
0.85%
Debt to Equity
0.53
Book Value
₹1.20
EPS (TTM)
₹0.00
52W High
₹1.79
52W Low
₹0.75

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Services › Commercial Services › Trading & Distributors

Redington
₹350.2516.1027,382 Cr2.691.68%12.32%19.00%1,28,312 Cr1,504 Cr
MMTC
₹51.5517.307,733 Cr3.650.00%18.27%29.75%908 Cr447 Cr
MSTC
₹567.8517.063,998 Cr4.422.82%24.16%31.29%478 Cr234 Cr
Creative Newtech
₹1,171.0023.871,758 Cr4.390.05%18.15%26.34%2,794 Cr74 Cr
Pervasive Commodities
——1,104 Cr12.250.00%-0.05%0.02%40 Cr-0 Cr
RRP Defense
——810 Cr59.900.00%53.72%74.36%12 Cr-2 Cr
Genpharmasec (this company)
——54 Cr0.810.00%0.85%2.43%181 Cr-1 Cr
Median 7 companies₹459.0517.181,758 Cr4.390.00%18.15%26.34%478 Cr74 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

45 Average
Overall score

Data confidence 91/100

Category scores

Quality Poor 32
Returns, margins, earnings quality 22% weight
Valuation Poor 33
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Poor 23
Solvency, leverage, coverage 9% weight
Momentum Poor 34
Trend strength, vol-adjusted 12% weight
Ownership Good 59
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Stock is trading at 0.92 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 111 to 76.3 days.
  • Company's working capital requirements have reduced from 132 days to 61.1 days

Weaknesses

7
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of 1.74% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.2.83 Cr.
  • Promoter holding has decreased over last 3 years: -30.0%

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
289% higher than 3Y

change over 1 year

Net Income Growth
-62.5% lower than 3Y

change over 1 year

Cash Flow Change
-695%

change over 1 year

EBITDA Margin Change
-67.45%

change over 1 year Operating margin 1.93% · Jun 2026

Quarterly Results

Particulars Mar 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
6.22
7.86
6.38
10.2
5.2
6.03
8.48
14.01
12.04
32.64
39.83
55.43
49.71
Expenses
6.01
7.89
6.37
10.21
5
5.9
7.76
15.01
11.1
33.1
41.07
53.44
48.75
Operating Profit
0.21
-0.03
0.01
-0.01
0.2
0.13
0.72
-1
0.94
-0.46
-1.24
1.99
0.96
OPM %
3.38%
-0.38%
0.16%
-0.1%
3.85%
2.16%
8.49%
-7.14%
7.81%
-1.41%
-3.11%
3.59%
1.93%
Other Income
0.06
0.15
0.14
0.31
0.57
0.75
0.81
0.94
0.69
0.46
0.98
1.02
0.37
Interest
0.06
0.07
0
0.16
0.1
0.07
0.16
0.11
0.12
0.23
0.41
0.48
0.4
Depreciation
0.01
0
0.12
0.03
0.16
0.3
0.1
0.26
0.27
0.56
0.67
0.68
0.67
PBT
0.2
0.05
0.03
0.11
0.51
0.51
1.27
-0.43
1.24
-0.79
-1.34
1.85
0.26
Tax %
-420%
80%
-100%
345.45%
35.29%
-39.22%
40.16%
-37.21%
2.42%
48.1%
-37.31%
27.03%
165.38%
Net Profit
1.05
0.01
0.06
-0.27
0.33
0.7
0.76
-0.27
1.22
-1.18
-0.83
1.36
-0.17
EPS (₹)
0.02
0
0
0
0.01
0.01
0.01
0
0.02
-0.02
-0.01
0.03
0
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
26
30
34
140
178
Expenses
25
30
33
139
176
Operating Profit
0
0
0
1
1
OPM %
1%
0.1%
1.2%
0.9%
0.7%
Other Income
0
1
3
3
3
Interest
0
0
0
1
2
Depreciation
0
0
1
2
3
PBT
0
0
2
1
0
Tax %
-300%
168%
29%
42%
—
Net Profit
1
0
2
1
-1
EPS (₹)
0.02
0
0.03
0.03
0
Div. Payout %
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
28
55
55
55
Reserves
-12
9
10
11
Borrowings
3
4
5
35
Other Liabilities
1
3
9
37
Total Liabilities
20
71
80
138
Fixed Assets
0
1
8
41
CWIP
0
0
0
0
Investments
1
19
20
2
Other Assets
19
51
53
95
Total Assets
20
71
80
138
Figures in ₹ Crores

Cash Flow

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-3
-3
3
-18
Investing
0
-28
-4
13
Financing
3
48
-1
4
Net Cash Flow
0
17
-3
0
Free Cash Flow
-3
-3
-3
-18
CFO/OP
-1,277
-7,275
774
-1,274
Figures in ₹ Crores

Ratios

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
109
147
76
Inventory Days
151
133
89
40
Days Payable
21
36
101
91
Cash Conversion Cycle
211
207
135
26
Working Capital Days
199
213
123
61
ROCE %
—
2%
4%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Genpharmasec insights

64 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

Public59.68%Others8.27%Promot.32.06%As ofSep 2026

Documents

Frequently Asked Questions about Genpharmasec

What does Genpharmasec Ltd do?
Incorporated in 1992, Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity shares[1]
Where is Genpharmasec Ltd (GENPHARMA) listed?
Genpharmasec Ltd trades under code 531592 on the BSE.
Which sector does Genpharmasec Ltd belong to?
Genpharmasec Ltd is classified under the Commercial Services sector, in the Trading & Distributors industry.
What is the market capitalisation of Genpharmasec Ltd?
Genpharmasec Ltd has a market capitalisation of ₹53.69 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Genpharmasec Ltd?
Over the last 52 weeks Genpharmasec Ltd has traded between ₹0.75 and ₹1.79 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Genpharmasec Ltd?
Genpharmasec Ltd reported a return on equity of 0.85%. Its debt-to-equity ratio is 0.53.

Company Information

Incorporated in 1992, Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity shares[1]

Website genpharmasec.com
CEO Mr. Sohan Chaturvedi
Employees 10
Face Value ₹ 1
Shares Outstanding 55,35,35,354

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531592.md for Genpharmasec Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Commercial Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month